|
|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MATERIALE ALE CONFERINȚELOR ȘTIINȚIFICE
- Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată: Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: Culegere de rezumate
- Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată: Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: Culegere de rezumate
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/32852
| Title: | Aspects of sensitization to major allergenic molecules of Ambrosia and Artemisia |
| Authors: | Paladii, Loridana Brocovschii, Victoria |
| Keywords: | Ambrosia;Artemisia;pollen;major molecules;sensitization |
| Issue Date: | 2026 |
| Publisher: | CEP Medicina |
| Citation: | PALADII, Loridana and Victoria BROCOVSCHII. Aspects of sensitization to major allergenic molecules of Ambrosia and Artemisia. In: Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată. Chişinău, 2026, p. 129. ISBN 978-9975-82-457-6. (Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: culegere de rezumate). |
| Abstract: | Background. Ambrosia artemisiifolia is an invasive plant from the Asteraceae family, with
22 described allergenic molecules. A single plant can produce billions of pollen grains during
peak season, frequently triggering allergic rhinitis. Amb a1 is considered the major allergen
and sensitizes 95% of affected patients.
Objective(s). To analyze the characteristics of sensitization to the major allergens of
Ambrosia artemisiifolia – Amb a1 and Artemisia vulgaris – Art v1 in patients examined at
the allergology outpatient clinic.
Materials and methods. A retrospective study was conducted, that included 751 patients
who were diagnosed with allergic rhinitis and were evaluated at the allergology outpatient
clinic between 2020 and 2025. Sensitization to the pollen of Ambrosia artemisiifolia and
Artemisia vulgaris has been assessed by using multiplex molecular allergy testing.
Results. Of the 751 patients, 52.2% were male and 47.8% female, the mean age was 21.5
years. Sensitization to ambrosia pollen was found in 24.1% patients (group 1–10.43%, gr. 2
– 37.36%, gr. 3–41.20%, gr. 4–7.14%, gr. 5–0.5%), Amb a1 pectate lyase 24.1% (gr. 1–7.2%,
gr. 2–32%, gr. 3–31.5%, gr. 4–23.2%, gr. 5–2.7%), Amb a4 defensin 9.18% (gr. 0–4.3%, gr.
1–7.2%, gr. 2–23.2%, gr. 3–42%, gr. 4–21.7%, gr. 5–1.4%), Artemisia 11.2% (gr. 1–16.6%,
gr. 2–38%, gr. 3–35.7%, gr. 4–2.4%), Art v1 defensin 12.38% (gr. 1–7.52%, gr. 2–32.3%, gr.
3–35.5%, gr. 4–18.3%), Art v3 LTP 3.6% (gr. 1–11%, gr. 2–40.7%, gr. 3–22.2%, gr. 4–14.8%,
gr. 5–3.7%).
Conclusion(s). In the Republic of Moldova, Ambrosia and Artemisia pollen represent major
sensitization sources for patients with respiratory allergic diseases. Sensitization to the
major allergens Amb a1 and Art v1 triggers hypersensitivity reactions in most individuals
sensitized to weed pollen. |
| metadata.dc.relation.ispartof: | Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată: Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: Culegere de rezumate |
| URI: | https://repository.usmf.md/handle/20.500.12710/32852 |
| ISBN: | 978-9975-82-457-6 |
| Appears in Collections: | Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată: Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: Culegere de rezumate
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|